Skip to content
← Full study record

NCT04608773 · OUTCOME

Saliva PH

Blinded Dry Mouth Spray Crossover Study · Source last updated 2024-02-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
units on a scale
Interval / dispersion
Standard Deviation
Time frame
2 week trial

What was measured

PH Is a measure of acidity on a logarithmic scale range 0 (most acidic) to 14 (most basic) with a neutral PH of 7 as the desired outcome.

Analysis population: The number of participants in this analysis are lower than the overall population due to missing data.

Groups in this outcome

Biotene Spray Trial

Participants who received Biotene in either the first or last two week trial period of the study.

Refresh Spray Trial

Participants who received Refresh spray in either the first or second two week trial period of the study.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Biotene Spray Trial96
Refresh Spray Trial96

Reported measurements

PH baseline

Analysis denominator · Participants

GroupSource count
Biotene Spray Trial91
Refresh Spray Trial91
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Biotene Spray Trial5.31.0Not reportedNot reportedNot reported
Refresh Spray Trial5.51.1Not reportedNot reportedNot reported
PH 2 weeks

Analysis denominator · Participants

GroupSource count
Biotene Spray Trial96
Refresh Spray Trial96
Values in units on a scale · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Biotene Spray Trial5.41.0Not reportedNot reportedNot reported
Refresh Spray Trial5.51.1Not reportedNot reportedNot reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    .486
    statistical Method
    ANCOVA
Complete source fields
analyses
  1. group Ids
    1. OG000
    2. OG001
    non Inferiority Type
    SUPERIORITY
    p Value
    .486
    statistical Method
    ANCOVA
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.0
        value
        5.3
      2. group Id
        OG001
        spread
        1.1
        value
        5.5
    denoms
    1. counts
      1. group Id
        OG000
        value
        91
      2. group Id
        OG001
        value
        91
      units
      Participants
    title
    PH baseline
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.0
        value
        5.4
      2. group Id
        OG001
        spread
        1.1
        value
        5.5
    denoms
    1. counts
      1. group Id
        OG000
        value
        96
      2. group Id
        OG001
        value
        96
      units
      Participants
    title
    PH 2 weeks
denoms
  1. counts
    1. group Id
      OG000
      value
      96
    2. group Id
      OG001
      value
      96
    units
    Participants
description
PH Is a measure of acidity on a logarithmic scale range 0 (most acidic) to 14 (most basic) with a neutral PH of 7 as the desired outcome.
dispersion Type
Standard Deviation
groups
  1. description
    Participants who received Biotene in either the first or last two week trial period of the study.
    id
    OG000
    title
    Biotene Spray Trial
  2. description
    Participants who received Refresh spray in either the first or second two week trial period of the study.
    id
    OG001
    title
    Refresh Spray Trial
param Type
MEAN
population Description
The number of participants in this analysis are lower than the overall population due to missing data.
reporting Status
POSTED
time Frame
2 week trial
title
Saliva PH
type
SECONDARY
unit Of Measure
units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice